Key Highlights
- RKLB shares increased approximately 1.1% to $75.67, reaching intraday peaks of $80.19
- Rocket Lab successfully executed its 92nd Electron launch, marking the 13th mission of 2026
- A $397 million Space Force contract was awarded for the SB-AMTI satellite initiative
- Combined Space Force agreements total roughly $663 million, contributing to a backlog near $2.2 billion
- Second quarter 2026 financial results scheduled for August 10; projections call for $231.79 million in revenue versus $144.50 million year-over-year
Shares of Rocket Lab advanced during Thursday’s trading session, peaking at $80.19 before closing near $75.67, representing approximately 1.1% growth from Wednesday’s close of $74.82.
The upward momentum followed an eventful period for the aerospace manufacturer, highlighted by a successful rocket deployment and multiple high-value government agreements that renewed investor enthusiasm.
The company’s 92nd Electron rocket successfully lifted off Thursday from its launch facility in Mahia, New Zealand. This deployment represented the eighth mission supporting the IQPS Earth observation constellation and marked Rocket Lab’s 13th Electron flight in 2026.
In a significant development, the United States Space Force granted Rocket Lab a $397 million agreement to build, launch, and manage Flatellite satellites for its Space-Based Airborne Moving Target Indicator initiative. The Flatellite system is specifically engineered for expansive satellite networks.
Adding a previously announced launch services agreement, Rocket Lab’s combined Space Force contract portfolio from recent weeks totals approximately $663 million. This brings the firm’s overall backlog to an estimated $2.2 billion.
Several SB-AMTI launches are contingent upon Rocket Lab’s Neutron launch vehicle, which remains in development and has not yet conducted its inaugural flight.
Wall Street Perspectives
Analysts maintain a generally optimistic view on RKLB shares. The consensus stands at “Moderate Buy” with an average price objective of $110.29 among tracked analysts on MarketBeat. KeyCorp leads with the highest target of $135, while Piper Sandler maintains a more conservative Neutral stance with an $83 projection.
On July 27, KGI Securities elevated Rocket Lab to an Outperform rating with a $107 price objective. Bank of America boosted its target from $105 to $115 in late June while maintaining its Buy recommendation.
Upcoming Quarterly Report
Market attention shifts to August 10, when Rocket Lab will unveil its second quarter 2026 financial performance following market close. Consensus estimates anticipate a 7-cent per share loss, an improvement from the 13-cent loss reported in the comparable quarter last year.
Analysts project revenue of $231.79 million, representing substantial growth from the prior year’s $144.50 million.
During the first quarter of 2026, Rocket Lab reported $200.35 million in revenue, a 63.4% year-over-year increase that surpassed analyst forecasts of $189.65 million.
The aerospace company maintains a market capitalization of $43.79 billion and shows a negative price-to-earnings ratio of -236.47. With a beta coefficient of 2.60, the stock demonstrates elevated volatility characteristic of the sector.
Company insiders have divested more than 3.8 million shares valued at approximately $362.8 million during the past three months. Chief Executive Peter Beck disposed of 990,960 shares on July 8 at an average of $82.86 per share, decreasing his ownership position by 36.5%.
Technical indicators show the 50-day moving average at $91.53 and the 200-day moving average at $85.99, both positioned above current trading levels.
Institutional investors control 71.78% of outstanding shares, with Bank of New York Mellon Corp establishing a new position valued at roughly $201.5 million during the second quarter.


